-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Seres Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2024.
- Seres Therapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $5.36M, a 38.3% increase year-over-year.
- Seres Therapeutics, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $17.3M, a 48.7% increase year-over-year.
- Seres Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $15.7M, a 100% increase from 2022.
- Seres Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $7.81M, a 14.5% increase from 2021.
- Seres Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $6.82M, a 8.24% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)